In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) Staphylococcus aureus Isolates

The high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections, always treated with vancomycin and daptomycin, has led to the emergence of vancomycin-intermediate (VISA), heteroresistant vancomycin-intermediate (hVISA) and daptomycin non-susceptible (DNS) S. aureus. Even if gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongiorno, Dafne, Lazzaro, Lorenzo Mattia, Stefani, Stefania, Campanile, Floriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761838/
https://www.ncbi.nlm.nih.gov/pubmed/33287376
http://dx.doi.org/10.3390/antibiotics9120865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761838/
https://www.ncbi.nlm.nih.gov/pubmed/33287376
http://dx.doi.org/10.3390/antibiotics9120865

Ejemplares similares